General Medicine

Medical Events

Contact us to enquire about advertising your events.

Professor Samar Ahmed
Professor Samar Ahmed
Professor Ahmed is an MD, JMHPE, FAIMER Fellow and faculty. She is the Director at Ain Shams Middle East North Africa FAIMER Regional Institute for Health Professions Education (menafri.faimefri.org).
Professor Samar Ahmed
Professor Samar Ahmed
Professor Samar Ahmed
Professor Ahmed is an MD, JMHPE, FAIMER Fellow and faculty. She is the Director at Ain Shams Middle East North Africa FAIMER Regional Institute for Health Professions Education (menafri.faimefri.org).

University’s Got Talent …. Not the Show

Professor Samar Ahmed discusses the importance of telling the story of your University.

Continue reading
Dr Amelie Hofmann-Werther
Dr Amelie Hofmann-Werther
Dr Hofmann-Werther is a Specialist Gynaecology and Obstetrics, Fetal Medicine Sonographer, Psychosomatics and Verbal Intervention Counselor, colposcopist, CBD surgeon, Conference Organization Team, Scientific Committee and Advisory Board Member OBFEGYN.
Dr Amelie Hofmann-Werther
Dr Amelie Hofmann-Werther
Dr Amelie Hofmann-Werther
Dr Hofmann-Werther is a Specialist Gynaecology and Obstetrics, Fetal Medicine Sonographer, Psychosomatics and Verbal Intervention Counselor, colposcopist, CBD surgeon, Conference Organization Team, Scientific Committee and Advisory Board Member OBFEGYN.

Truffle Hunting: It’s all about the right chemistry! Or – metaphorically speaking, “love is in the air.”

Dr Amelie Hofmann-Werther discusses the chemistry of love highlighting including the science behind pheromones.

Continue reading

View references

1. Darwin, C. 1859. The origin of species. London, Penguin Books.

 

2. Darwin, C. 1871. The descent of man and selection in relation to sex. London, Murray.

 

3. Darwin’s sexual selection theory – a forgotten idea

4. Paulo Gama Mota Departamento de Ciências da Vida Universidade de Coimbra, Portugal. https://www.uc.pt/en/cia/publica/AP_artigos/AP26.27.10_paulomota

 

6. Influence of HLA on human partnership and sexual satisfaction J. Kromer1, T. Hummel1, D. Pietrowski1, A. S.Giani2, J. Sauter2, G. Ehninger3, A. H. Schmidt2 & I. Croy1,4 https://cyberleninka.org/article/n/676372.pdf

 

7. Male steroid hormones and female preference for male body odor, Markus J. 8 Rantalaa,*,1, C.J. Peter Erikssonb , Anssi Vainikkaa , Raine Korteta,2 a Department of 9 Biological and Environmental Science, University of Jyva¨skyla¨, P.O. Box 35, FIN-40014 10 Jyva¨skyla¨, Finland b Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, Finland http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.391.8996&rep=rep1&type=pdf

Dr Arthur Cassidy (Phd)
Dr Arthur Cassidy (Phd)
Dr Cassidy holds honours degrees from the University of Ulster and his Post Graduate research Doctorate in Personality and Social Relationships from the Queens University of Belfast. He is a Chartered Psychologist and an Associate Fellow of the British Psychological Society. Dr Cassidy has taught, lectured, and examined in various specialties within psychology in Universities and was a visiting Lecturer to the Hong Kong Polytechnic. He is a well-established Social Media and Personality Psychologist who has made a dynamic and energetic impact to contemporary television programmes by bringing fresh insight into evidence-based psychological aspects of a wide range of topics.
Dr Arthur Cassidy (Phd)
Dr Arthur Cassidy (Phd)
Dr Arthur Cassidy (Phd)
Dr Cassidy holds honours degrees from the University of Ulster and his Post Graduate research Doctorate in Personality and Social Relationships from the Queens University of Belfast. He is a Chartered Psychologist and an Associate Fellow of the British Psychological Society. Dr Cassidy has taught, lectured, and examined in various specialties within psychology in Universities and was a visiting Lecturer to the Hong Kong Polytechnic. He is a well-established Social Media and Personality Psychologist who has made a dynamic and energetic impact to contemporary television programmes by bringing fresh insight into evidence-based psychological aspects of a wide range of topics.

Cyberpsychology: The dangers of Internet and gadget addiction

Cyberpsychology is a new field within applied psychology, it assesses how we interact with others using technology and how technology influences our daily behaviour. Dr Arthur Cassidy Cyberpsychology and the dangers of Internet and gadget addiction.

Continue reading

View references

1. Cheng C, Li AY. Internet addiction prevalence and quality of (real) life: a meta-analysis of 31 nations across seven world regions. Cyberpsychol Behav Soc Netw. 2014;17(12):755–760. doi:10.1089/cyber.2014.0317 Accessed at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267764/

Dr Mokhamed Orabi
Dr Mokhamed Orabi
Dr Mokhamed Orabi is an experienced specialty doctor in the Obstetric and Gynecology Department at St Mary’s Hospital, Isle of Wight Trust. He is a member of the Royal College of Obstetricians and the Royal College of Obstetricians Gynecologists MRCOG London and has Diplomate in Obstetrics & Gynecology from College of medicine of South Africa ( Dip Obst SA) CMSA; Clinical Ordinatura O&G (MD) - M Gorky Donetsk State University and a MBChB from Baghdad University. His Special interest are feto-maternal medicine ,colposcopy and medical education.
Dr Mokhamed Orabi
Dr Mokhamed Orabi
Dr Mokhamed Orabi
Dr Mokhamed Orabi is an experienced specialty doctor in the Obstetric and Gynecology Department at St Mary’s Hospital, Isle of Wight Trust. He is a member of the Royal College of Obstetricians and the Royal College of Obstetricians Gynecologists MRCOG London and has Diplomate in Obstetrics & Gynecology from College of medicine of South Africa ( Dip Obst SA) CMSA; Clinical Ordinatura O&G (MD) - M Gorky Donetsk State University and a MBChB from Baghdad University. His Special interest are feto-maternal medicine ,colposcopy and medical education.

Undiagnosed live term extra-uterine abdominal pregnancy

Introduction Abdominal pregnancy usually presents with signs and symptoms before the pregnancy reaches an advanced stage. They pose a high-risk to the mother and the baby, mainly due to the risk of bleeding and poor placental implantation respectively. Case overview I present a case of advanced abdominal pregnancy. The pregnancy reached 40+5/40 without any signs or symptoms and with a

Continue reading

View references

1. Atrash, H.K., A. Friede, and C.J. Hogue, Abdominal pregnancy in the United States: frequency and maternal
mortality. Obstet Gynecol, 1987. 69(3 Pt 1): p. 333-7.

2. Authors:, M. Thomas A Molinaro, and M. Kurt T Barnhart, MSCE, Abdominal pregnancy, cesarean scar pregnancy, and heterotopic pregnancy. 2018.

3. Baffoe, P., C. Fofie, and B.N. Gandau, Term abdominal pregnancy with healthy newborn: a case report. Ghana medical journal, 2011. 45(2): p. 81-83.

4. Mengistu, Z., A. Getachew, and M. Adefris, Term abdominal pregnancy: a case report. Journal of medical case reports, 2015. 9: p. 168-168.

5. Zhang, J., F. Li, and Q. Sheng, Full-term abdominal pregnancy: a case report and review of the literature. Gynecologic and obstetric investigation, 2008. 65(2): p. 139-141.

6. Adesiyun, A.G. and A.I. Audu, Term extrauterine pregnancy in a Nigerian mother: a complication of uterine dehiscence. Archives of gynecology and obstetrics, 2009. 279(1): p. 75.

7. Buchmann, P.E., GUIDELINES FOR MATERNITY CARE IN SOUTH AFRICA. 2015.

8. Agarwal, N. and F. Odejinmi, Early abdominal ectopic pregnancy: challenges, update and review of current management. The Obstetrician & Gynaecologist, 2014. 16(3): p. 193-198.

9. Martin, J.N. and J.F. McCaul, EMERGENT MANAGEMENT OF ABDOMINAL PREGNANCY. Clinical Obstetrics and Gynecology, 1990. 33(3): p. 438-447.

10 Costa, S., J. Presley, and G. Bastert, Advanced abdominal pregnancy. Obstetrical & gynecological survey, 1991. 46(8): p. 515-525.

11 Sagili, H. and K. Mohamed, Pregnancy of unknown location: an evidence-based approach to management. The Obstetrician & Gynaecologist, 2008. 10(4): p. 224-230.

Dr Ahmed Yasser Soliman
Dr Ahmed Yasser Soliman
Dr Soliman is a strategic visionary healthcare leader with over 30 years’ experience in Egypt and the Gulf region. He has led and participated in multinational teams in the operation and management of more than 5 highly qualified JCI accredited hospitals in the region. Dr Soliman is a qualified Medical Doctor (MD) and has an MBA qualification from Aberdeen University. He is a well-known Professor in International Healthcare Management affiliated with the Academy of Leadership Science Switzerland, and a number of other Leadership institutes in Egypt.
Dr Ahmed Yasser Soliman
Dr Ahmed Yasser Soliman
Dr Ahmed Yasser Soliman
Dr Soliman is a strategic visionary healthcare leader with over 30 years’ experience in Egypt and the Gulf region. He has led and participated in multinational teams in the operation and management of more than 5 highly qualified JCI accredited hospitals in the region. Dr Soliman is a qualified Medical Doctor (MD) and has an MBA qualification from Aberdeen University. He is a well-known Professor in International Healthcare Management affiliated with the Academy of Leadership Science Switzerland, and a number of other Leadership institutes in Egypt.

Egypt; The promising land of Healthcare Investment

Egypt is the most populous Arab country in the world and has a growing population rate. The demand for healthcare services is expected to grow continuously with Egypt requiring an additional 26,000 beds (at 1.5 beds / 1,000 population) with an investment of $6 billion to $9 billion. Dr Soliman highlights the healthcare investment opportunities.

Continue reading
Dr Lama El Zein, MD, FAAFP, FAAHPM
Dr Lama El Zein, MD, FAAFP, FAAHPM
Dr Lama El Zein is an experienced physician with a demonstrated history of working in the medical practice and healthcare industry. She is a healthcare leader with experience in training and overseeing residents and medical students. Dr El Zein currently practices Family Medicine and Palliative care at Summit Medical Group in NJ and is currently enrolled in the Executive Master in Health Administration at Columbia University Mailman School of Public Health in NYC. She is an adjunct assistance professor of Medicine at the Center of Family and Community medicine at Columbia University in NY where she was a full-time faculty for three years between 2012 and 2015.
Dr Lama El Zein, MD, FAAFP, FAAHPM
Dr Lama El Zein, MD, FAAFP, FAAHPM
Dr Lama El Zein, MD, FAAFP, FAAHPM
Dr Lama El Zein is an experienced physician with a demonstrated history of working in the medical practice and healthcare industry. She is a healthcare leader with experience in training and overseeing residents and medical students. Dr El Zein currently practices Family Medicine and Palliative care at Summit Medical Group in NJ and is currently enrolled in the Executive Master in Health Administration at Columbia University Mailman School of Public Health in NYC. She is an adjunct assistance professor of Medicine at the Center of Family and Community medicine at Columbia University in NY where she was a full-time faculty for three years between 2012 and 2015.

Palliative care in the Middle East

In the Middle East, the growth of palliative care is still in its early stages. Dr Lama El Zein discusses how providing palliative care has shown to have extensive benefits for patients with serious illnesses by improving quality of life, decreasing unnecessary cost and improving care throughout the illness.

Continue reading

View references

1. Kelley, A. S., & Morrison, R. S. (2015). Palliative Care for the Seriously Ill. New England Journal of Medicine, 373(8), 747–755. https://doi.org/10.1056/NEJMra1404684

2. WHO | WHO Definition of Palliative Care. (n.d.). Retrieved October 26, 2018, from WHO website: http://www.who.int/cancer/palliative/definition/en/

3. National Institute on Aging. What Are Palliative Care and Hospice Care? (n.d.). Retrieved April 25, 2019, from National Institute on Aging website: https://www.nia.nih.gov/health/what-are-palliative-care-and-hospice-care

4. Murray. S., Osman. H., WHO EMRO | Primary palliative care: the potential of primary care physicians as providers of palliative care in the community in the Eastern Mediterranean Region | Volume 18, issue 2 | EMHJ volume 18, 2012.. Retrieved October 28, 2018, from http://www.emro.who.int/emhj-volume-18-2012/issue-2/article-11.html

5. Zeinah, G. F. A., Al-Kindi, S. G., & Hassan, A. A. (2013). Middle East Experience in Palliative Care. American Journal of Hospice and Palliative Medicine®, 30(1), 94–99. https://doi.org/10.1177/1049909112439619

6. Shamieh, O., & Hui, D. (2015). A Comprehensive Palliative Care Program at a Tertiary Cancer Center in Jordan. American Journal of Hospice and Palliative Medicine®, 32(2), 238–242. https://doi.org/10.1177/1049909113513316

7. Wright, A. A., Zhang, B., Ray, A., Mack, J. W., Trice, E., Balboni, T., … Prigerson, H. G. (2008). Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement Adjustment. JAMA, 300(14), 1665–1673. https://doi.org/10.1001/jama.300.14.1665

8. Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., … Lynch, T. J. (2010). Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer. New England Journal of Medicine, 363(8), 733–742. https://doi.org/10.1056/NEJMoa1000678

9. Meier, D. E., Back, A. L., Berman, A., Block, S. D., Corrigan, J. M., & Morrison, R. S. (2017). A National Strategy For Palliative Care. Health Affairs; Chevy Chase, 36(7), 1265–1273. http://dx.doi.org.ezproxy.cul.columbia.edu/10.1377/hlthaff.2017.0164

10. DiBello, K. M., & Coyne, N. M. (2014). Palliative Care Hits a Triple Win: Access, Quality, and Cost. Home Healthcare Nurse, 32(3), 183–190. https://doi.org/10.1097/NHH.0000000000000026

11. Johnson, D. (2018).Enhanced Physician Training And Support Are Needed To Improve End-Of-Life Care. Health Affairs Blog. August 2, 2018. Retrieved November 3, 2018, from https://www.healthaffairs.org/do/10.1377/hblog20180730.54577/full/

12. OHCHR | Right to pain relief: 5.5 billion people have no access to treatment, warn UN experts World Hospice and Palliative Care Day – Saturday 10 October 2015. Retrieved April 25, 2019, from https://www.ohchr.org/en/NewsEvents/Pages/DisplayNews.aspx?NewsID=16590&LangID=E

13. WHA67.19 – Strengthening of Palliative Care as a Component of Comprehensive Care Throughout the Life Course. WHA Resolution; Sixty-seventh World Health Assembly, 2014 . Retrieved October 30, 2018, from http://apps.who.int/medicinedocs/en/d/Js21454ar/

 

Susannah Makram
Susannah Makram
Susannah Makram is a registered Osteopath with a wealth of knowledge and experience in the pathophysiology of the ageing spine and optimising tissue health. She is a specialist at BVLGARI Hotels London and practices at the Chelsea Private Clinic. Susannah also works with athletes and families around the world.
Susannah Makram
Susannah Makram
Susannah Makram
Susannah Makram is a registered Osteopath with a wealth of knowledge and experience in the pathophysiology of the ageing spine and optimising tissue health. She is a specialist at BVLGARI Hotels London and practices at the Chelsea Private Clinic. Susannah also works with athletes and families around the world.

When and how to treat back pain

A large majority of people will experience back pain at some point in their lives. It is estimated that 540 million people globally are affected by low back pain and it is the main cause of disability worldwide. A peer-reviewed research study concluded that the highest prevalence of low back pain is in Western Europe, followed by the MENA region

Continue reading

View references

  1. Clark, S. and Horton, R. (2018). Low back pain: a major global challenge. The Lancet, 391(10137), p.2302. URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30725-6/fulltext

2. Harvard men’s Health watch, Dec 2018

3.  Pud med Mt Sinai J Med. 1991 May;58(3):217-20., Grichnik KP1Ferrante FM.

Editor
Editor
Editor
Editor
Editor

Urine test could prevent cervical cancer

Urine testing may be as effective as the smear test at preventing cervical cancer, according to a study published in the journal BMJ Open.

Continue reading
Osama Atif
Osama Atif
Osama is a biotechnology undergraduate student at the Faculty of Science, Mansoura University and a student researcher at biotechnology field. He is interested in Medical Genetics and Molecular Pathology.
Osama Atif
Osama Atif
Osama Atif
Osama is a biotechnology undergraduate student at the Faculty of Science, Mansoura University and a student researcher at biotechnology field. He is interested in Medical Genetics and Molecular Pathology.

Disorder of thalassemias and hemoglobinopathies: A genetic overview

The thalassemia syndromes are genetic disorders characterized by absent or deficient synthesis of one or more of the normal globin chains. Biotechnologist Osama Atif provides an overview of these gentic disorders.

Continue reading

View references

Cappellini MD. The thalassemias. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 162.

Chapin J, Giardina PJ. Thalassemia syndromes. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 7th ed. Philadelphia, PA: Elsevier; 2018:chap 40.

Weatherall, David J., and John B. Clegg. The thalassaemia syndromes. John Wiley & Sons, 2008.

Schrier, Stanley L. “Pathophysiology of thalassemia.” Current opinion in hematology 9.2 (2002): 123-126.

Chui DH, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood. 1998;91:2213–22.

Higgs DR, Bowden DK. Clinical and laboratory features of the alpha-thalassemia syndromes. In: Steinberg MH, Forget PG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge, UK: Cambridge University Press; 2001:431-69.

Coelho A, Picanço I, Seuanes F, Seixas MT, Faustino P. Novel large deletions in the human alpha-globin gene cluster: Clarifying the HS-40 long-range regulatory role in the native chromosome environment. Blood Cells Mol Dis. 2010;45:147–53.

Chui DH: Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci. 2005, 1054: 25-32. 10.1196/annals.1345.004.

Ingram VM, Stretton AO: Genetic basis of the thalassaemia diseases. Nature. 1959, 184: 1903-1909. 10.1038/1841903a0.

Bernini L: Geographic distribution of alpha-thalassemia. Disorders of Hemoglobin. first edition. Edited by: Steinberg MH, Forget BG, Higgs DR, Nagel RL. Cambridge University Press; 2001:878-894.

Ko T, Hsieh FJ, Hsu PM, Lee TY. Molecular characterization of severe α-thalassemias causing hydrops fetalis in Taiwan. Am J Med Genet 1991; 39: 317–320.

Steensma DP, Viprakasit V, Hendrick A, Goff DK, Leach J, Gibbons RJ, Higgs DR. Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome. Blood. 2004b;103:1518–20.

Galanello, Renzo, and Raffaella Origa. “Beta-thalassemia.” Orphanet journal of rare diseases 5.1 (2010): 11.

Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-712.

Weatherall DJ. Hemoglobinopathies worldwide: Present and future. Curr Mol Med. 2008;8:592–599

Steinberg MH, Forget BG, et al., editors. Disorders of hemoglobin: genetics, pathophysiology and clinical management. Cambridge University Press; 2001.

Verma S, Bhargava M, Mittal S, Gupta R. Homozygous delta-beta thalassemia in a child: a rare cause of elevated fetal hemoglobin. Iran J Ped Hematol Oncol. 2013;3:222–227.

Bollekens JA, Forget BG. Delta beta thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am. 1991;5:399–422.

Forget, Bernard G. “Molecular basis of hereditary persistence of fetal hemoglobin.” Annals of the New York Academy of Sciences850.1 (1998): 38-44.

Bollekens, J. A. & B. G. Forget. 1991. δγ Thalassemia and hereditary persistence of fetal hemoglobin. Hematol. Oncol. Clin. North Am. 5: 399–422.

Editor
Editor
Editor
Editor
Editor

Discovery may lead to precision-based strategy for triple negative breast cancer

According to the paper now available online, TP53 is the most frequently mutated gene in triple negative breast cancer, meaning it is fuelling the growth of this aggressive form of breast cancer. However, the problem with trying to target mutated TP53, specifically, is that it is not a druggable target, because of its potential toxicity – or ability to kill – nearby healthy cells.

Continue reading

Subscribe to our mailing list

Overlay